AYTU BIOPHARMA, INC
AYTU · Pharmaceutical Preparations
Latest available SEC filing: 10-K ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-K
SEC filing · Filed
-
Disbrow Joshua R.: Form 4
Insider disclosure · Filed · Report period 28 Jul 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001385818 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- AYTU on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 7900 E. Union Avenue, Suite 920, Denver, CO, 80237
- Incorporated in
- DE
- Fiscal year end
- 30 June
- Former names on EDGAR
- AYTU BIOSCIENCE, INC (to 22 Mar 2021), Rosewind CORP (to 08 Jun 2015)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields